Insulet Corp (STU:GOV)
€ 228.1 5 (2.24%) Market Cap: 17.41 Bil Enterprise Value: 17.87 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 93/100

Insulet Corp at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 07:20PM GMT
Release Date Price: €154 (+1.99%)
Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

Hi, good afternoon, everybody. Welcome to the Barclays Virtual Global Health Care Conference. I'm Kristen Stewart, the medical supplies and devices analyst. It is my pleasure to kick off this session with Insulet Corporation.

With me today, I have Wayde McMillan, the Executive Vice President, Chief Financial Officer and Treasurer; Bret Christensen, Executive Vice President and Chief Commercial Officer; and Deb Gordon, Vice President, Investor Relations and Corporate Communications.

If you're listening on the webcast and you would like to ask a question, you can e-mail me at [email protected]. You can also chat me on Bloomberg chat. I am actively monitoring my chat screen.

Questions & Answers

Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

All right, guys. Thanks for joining me. I'm going to start off today's session with a question here on the topic of the day, which should probably catch you by no surprise,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot